Evaluasi Peracikan Injeksi Seftriakson di Salah Satu Rumah Sakit Swasta di Semarang
Abstract
Injeksi seftriakson merupakan antibiotik spektrum luas golongan sefalosporin generasi ketiga, yang dalam penggunaannya di rumah sakit memerlukan proses peracikan, yaitu rekonstitusi dan pengenceran. Sesuai dengan peraturan dan pedoman yang berlaku, peracikan sediaan steril harus dilakukan dengan fasilitas yang sesuai, proses peracikan yang aseptis, dan dilakukan oleh tenaga kefarmasian, sehingga diperoleh sediaan dengan kualitas dan stabilitas yang baik. Penelitian ini bertujuan mengamati proses peracikan dan sifat fisik hasil peracikan sediaan injeksi seftriakson yang dilakukan di salah satu rumah sakit swasta di Semarang dalam periode April–Mei 2017. Penelitian dilakukan secara observasional terhadap personel peracik, fasilitas dan proses peracikan sediaan injeksi seftriakson. Observasi dilakukan dengan bantuan ceklis yang disesuaikan dengan pedoman pencampuran obat suntik dan penanganan sitostatika. Sebanyak 60 proses peracikan injeksi seftriakson digunakan sebagai sampel. Hasil peracikan dengan kondisi proses paling tidak sesuai dengan pedoman diuji kualitas fisiknya meliputi pH, kejernihan dan sterilitas. Hasil penelitian menunjukkan bahwa peracikan sediaan injeksi seftriakson di rumah sakit tersebut belum memenuhi kriteria sesuai pedoman pencampuran obat suntik, terutama dari segi fasilitas dan personel peracik. Meskipun demikian, hasil uji kualitas yang dilakukan terhadap sediaan tersebut masih memenuhi kriteria bebas kuman, isohidris, dan jernih.
Kata kunci: Injeksi, peracikan, seftriakson, steril
Evaluation of Ceftriaxone Injection Compounding in One of Private Hospital in Semarang
Abstract
Ceftriaxone injection is a broad-spectrum antibiotic of third-generation cephalosporin. Its use in hospitals requires reconstitution and dilution to obtain the desired dose. Compounding of sterile preparations is supposed to be carried out with appropriate facilities, aseptic compounding process, and performed by a pharmacist, in accordance with regulations and guidelines, to obtain a good quality and stability of ceftriaxone injection. The aim of this study was to evaluate the compounding process of ceftriaxone injection preparation in one of a private hospital in Semarang at April–May 2017.The study was done by observing the compounding of ceftriaxone injection preparations involving the facility, process, and personnel. Observations were conducted using the checklist from Sterile Dispensing Guidelines. Sixty compounding of ceftriaxone injection were used as samples. Observation results were used to determine the process of compounding with the worst possible condition, and then pH, clarity, and sterility were tested to evaluate its physical quality. The results showed that compounding of ceftriaxone injection in the hospital do not conform the criteria according to the preparation of injectable guidelines, especially in terms of facilities and personnel. However, the results of quality tests performed still accord the criteria, i.e, free from microbe, isohydris and clear.
Keywords: Ceftriaxone, injection, compounding, sterile
Keywords
Full Text:
PDF (Bahasa Indonesia)References
Ministry of Health of the Republic of Indonesia. Mixing guidelines for injectable drug and cytostatic. Directorate of Community Pharmacy and Clinic of the Ministry of Health of the Republic of Indonesia; 2009.
Ministry of Health of the Republic of Indonesia. Basic guidelines for sterile dispensing. Directorate of Community Pharmacy and Clinic of the Ministry of Health of the Republic of Indonesia; 2009.
Gudeman J, Jozwiakowski M, Chollet J, Randell M. Potential risks of pharmacy compounding. Drugs R D. 2013;13(1):1–8. doi: 10.1007/s40268-013-0005-9
United States Pharmacopeia Convention. USP36 NF31, 2013: U. S. Pharmacopeia national formulary. United States: United States Pharmacopeial; 2012.
Rich DS, Fricker MP Jr, Cohen MR, Levine SR. Guidelines for the safe preparation of sterile compounds: Results of the ISMP sterile preparation compounding safety summit of October 2011. Hosp Pharm. 2013;48(4):282–94. doi: 10.1310/hpj4804-282
Ulfa FN, Achmad A, Triastuti E. Aseptic dispensing compliance test based on basic guidelines for dispensing sterile provision of the Ministry of Health of the Republic of Indonesia in ICU and NICU RSUD Dr. Saiful Anwar Malang. Pharmaceutical J Indones. 2017;3(1):33–8
Surahman E, Mandalas E, Kardinah EI. Evaluation using of sterile preparation by i.v. for infection disease in one of private hospital in Bandung. Pharm Sci Res. 2012; 5(1). doi: 10.7454/psr.v5i1.3416
Agyemang REO, While A. Medication errors: Types, causes and impact on nursing practice. Br J Nurs. 2010;19(6):380–5. doi: 10.12968/bjon.2010.19.6.47237
Myers CE. History of sterile compounding in U.S. hospitals: Learning from the tragic lessons of the past. Am J Health Syst Pharm. 2013;70(16):1414–27. doi: 10.2146/ajhp130112
Sidabutar S, Satari HI. Choice of empiric therapy of typhoid fever in children: Chloramphenicol or ceftriaxone?. Sari Pediatri. 2016;11(6):434–9. doi: 10.14238/sp11.6.2010.434-9
Ekawati RN, Subarnas A, Rostinawati T. Evaluation of bacterial sensitivity causes of pneumonia against antibiotics amoxicillin, sefadroksil, trimethoprim, sulfamethoxazole, ceftriaxone and cefecular -based cefotaxime at Regional General Hospital Dr. Slamet Regency of Garut. Farmaka. 2017;15(2):1–10. doi: 10.24198/jf.v15i2.12338.g5733
Niranjan V, Malini A. Antimicrobial resistance pattern in Escherichia coli causing urinary tract infection among inpatients. Indian J Med Res. 2014;139(6):945–8.
Trissel LA. Handbook on injectable drugs. United States: American Society of Health -System Pharmacists; 2011.
Westbrook JI, Rob MI, Woods A, Parry D. Errors in the administration of intravenous medications in hospital and the role of correct procedures and nurse experience. BMJ Qual Saf. 2011;20(12):1027–34. doi: 10.1136/bmjqs-2011-000089
Grissinger M. Reducing errors with injectable medications. Pharm Ther. 2010; 35(8):428–51.
Regulation of the Minister of Health No. 72 Year 2016 about the Standard of Pharmaceutical Care at the Hospital. Ministry of Health of the Republic of Indonesia; 2016.
Ding Q, Barker KN, Flynn EA, Westrick S., Chang M, Thomas RE, et al. Incidence of intravenous medication errors in a Chinese hospital. Value Health Reg Issues. 2015;(6):33–9. doi: 10.1016/j.vhri.2015.03.004
Thomas M, Sanborn MD, Couldry R. I.V. admixture contamination rates: Traditional practice site versus a class 1000 cleanroom. Am J Health Syst Pharm. 2005;62(22):23 86–92. doi: 10.2146/ajhp050078
Maharani L, Achmad A, Utami ED. The effect of pharmacist education on the attitudes and knowledge of nurses about parenteral preparations. J Keperawatan Soedirman. 2013;8(2):87–91. doi: 10.208 84/1.jks.2013.8.2.472
Bülbül A, Kunt A, Selalmaz M, Sözeri Ş, Uslu S, Nuhoğlu A. Assessment of knowledge of pediatric nurses related with drug administration and preparation. Turk Arc Pediatri. 2014;49(4):333–9. doi: 10.5152/tpa.2014.1751
Berdot S, Roudot M, Schramm C, Katsahian S, Durieux P, Sabatier B. Interventions to reduce nurses’ medication administration errors in inpatient settings: A systematic review and meta-analysis. Int J Nurs Stud. 2016;(53):342–50. doi: 10.1016/j.ijnurstu.2015.08.012
Elnour A, Ellahham N, Al Qassas H. Raising the awareness of inpatient nursing staff about medication errors. Pharm World Sci. 2008;(30):182–190. doi: 10.1007/s11096-007-9163-6
Stucki C, Sautter A-M, Favet J, Bonnabry P. Microbial contamination of syringes during preparation: The direct influence of environmental cleanliness and risk manipulations on end-product quality. Am J Health Syst Pharm. 2009;66(22):2032–6. doi: 10.2146/ajhp070681
Allen JL, Okeke CC. Basics of compounding; Considerations for implementing United States Pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 13. Int J Pharm Compd. 2009;13(3):234–8.
Austin PD, Elia M. A systematic review and meta-analysis of the risk of microbial contamination of aseptically prepared doses in different environments. J Pharm Pharm Sci. 2009;12(2):233–42. doi: 10.18433/J3JP4B
Smeulers M, Verweij L, Maaskant JM, de Boer M, Krediet CP, van Dijkum EJN, et al. Quality indicators for safe medication preparation and administration: A systematic review. PloS One. 2015;10(4):e0122695. doi: 10.1371/journal.pone.0122695
Kampf G, Löffler H, Gastmeier P. Hand hygiene for the prevention of nosocomial infections. Dtsch Ärztebl Int. 2009;106(40):649–55. doi: 10.3238/arztebl.2009.0649
Sari RY, Suprapti E, Solechan A. Effect of SOP socialization with nurse behavior in the use of PPE (Handscoon, mask, gown) in Dr. H. Soewondo Hospital. Karya Ilmiah S.1 Ilmu Keperawatan. 2014;1(6):1–10
Hemingway CJ, Malhotra S, Almeida M, Azadian B, Yentis SM. The effect of alcohol swabs and filter straws on reducing contamination of glass ampoules used for neuroaxial injections. Anaesthesia. 2007; 62(3):286–8. doi: 10.1111/j.1365-2044.2007.04977.x
Mullarkey T. Pharmacy compounding of high-risk level products and patient safety. Am J Health Syst Pharm. 2009;66(17 Suppl 5):S4–13. doi: 10.2146/ajhp0108b
Amin R, Gul R, Mehrab A. Hospital waste management. Prof Med J. 2013;20(6):988 –94.
Okeke CC, Allen LV. Basics of compounding: Considerations for implementing United States Pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 15: Personnel training, cleansing, and garbing. Int J Pharm Compd. 2009;11(5):420–6.
Reference PD. 2017 PDR drug information handbook. PDR Network, LLC; 2016.
Utami ER. Antibiotics, resistance, and rationality of therapy. el–Hayah. 2012;1 (4):191–8. doi: 10.18860/elha.v1i4.1783
Cohen MR, Smetzer JL. Errors with injectable medications: Unlabeled syringes are surprisingly common; Unintended consequences of high-alert stickers; Easily misread abbreviations. Hosp Pharm. 2008; 43(2):81–84. doi: 10.1310/hp j4302-81
Kastango ES, Bradshaw BD. Sterile product compounding: Developing quality -based standards for pharmacy practice. Infusion. 2003;9(1):23–7.
Herawati F. Beyond use date of sterile product. Rasional. 2012;10(3):22–4.
Allen JL, Okeke CC. Basics of compounding: Considerations for implementing United States Pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: Stability and beyond-use dating. Int J Pharm Compd. 2008;12(4):344–53.
Allen JL, Okeke CC. Considerations for implementing United States Pharmacopeia chapter 797 pharmaceutical compounding-sterile preparation, part 3: Risk levels. Int J Pharm Compd. 2007;11(5):404–10.
Gorski LA, Hagle ME, Bierman S. Intermittently delivered IV medication and pH: reevaluating the evidence. J Infus Nurs. 2015;38(1):27–46. doi: 10.1097/NAN.0000000000000081
Okeke CC, Allen JL. Basics of compounding: Considerations for implementing United States Pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 16: Suggested standard operating procedures. Int J Pharm Compd. 2009;13(6):546–53.
DOI: https://doi.org/10.15416/ijcp.2018.7.3.143
Refbacks
- There are currently no refbacks.
Indonesian Journal of Clinical Pharmacy is indexed by